Supplemental information for PAR-16-357
Program Announcements
- Cutting-Edge Basic Research Awards (CEBRA) - PAR-15-079 (R21)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products - PAR-15-071 (R21/R33)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery - PAR-15-070 (R21/R33)
- Role of Astrocytes and Astrocytic Networks in Drug Abuse - PA-16-144 (R01)
- Role of Astrocytes and Astrocytic Networks in Drug Abuse - PA-16-145 (R21)
- The Application of Big Data Analytics to Drug Abuse Research - PA-16-119 (R01)
- Behavioral Science Track Award for Rapid Transition (B/Start) - PAR-16-071 (R03)
- Drug Discovery For Nervous System Disorders - PAR-16-041 (R01)
- Drug Discovery For Nervous System Disorders - PAR-16-042 (R21)
- Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing - PA-15-347 (R01)
- HIV/AIDS High Priority Drug Abuse Research - PAS-16-018 (R01)
- NIDA Research Center of Excellence Grant Program - PAR-16-009 (P50)
- AIDS-Science Track Award for Research Transition - PA-15-290 (R03)
- Imaging - Science Track Award for Research Transition (I/START) - PAR-15-326 (R03)
- Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science - PAR-15-288 (R44)
- Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment - PA-15-188 (R01)
- Identification of Genetic and Genomic Variants by Next-Gen in Sequencing Non-human Animal Models - PAR-15-120 (U01)
- BRAIN Initiative: Optimization of Novel Tools and Technologies for Neuroscience Research - PAR-15-121 (R44)
- BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) - PAR-15-091 (R43/R44)
- BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) - PAR-15-090 (R41/R42)
- Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research - PAR-15-085 (U01)
- Building on High Impact Basic Neurobiology Through Assay Development: Advancing Tools for Therapeutic Discovery - PAR-15-066 (R01)
- Promoting Research in Basic Neuroscience - PAS-15-029 (R01)
- Mechanistic Studies of Pain and Alcohol Dependence - PA-15-026 (R01)
- Platform Delivery Technologies for Nucleic Acid Therapeutics - PA-14-308 (R41/R42)
- Platform Delivery Technologies for Nucleic Acid Therapeutics - PA-14-307 (R43/R44)
- High Throughput Screening (HTS) to Discover Chemical Probes - PAR-14-283 (R21)
- High Throughput Screening (HTS) to Discover Chemical Probes - PAR-14-284 (R01)
- Connectomes Related to Human Disease - PAR-14-281 (U01)
- Discovery of in vivo Chemical Probes - PAR-14-279 (R01)
- Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Program - PA-14-278 (R21)
- Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program - PA-14-276 (R01)
- Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program - PA-14-277 (R03)
- Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program BRCP) - U.S. Entity (Administrative Supplement) - PA-14-249
- National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction - PAR-14-184 (U01)
- National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction - PAR-14-234 (U19)
- Effects of Cannabis Use and Cannabinoids on the Developing Brain - PA-14-162 (R21)
- Effects of Cannabis Use and Cannabinoids on the Developing Brain - PA-14-163 (R01)
- Effects of Cannabis Use and Cannabinoids on the Developing Brain - PA-14-164 (R03)
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science - PA-14-157 (R41/R42)
- Extended Development, Hardening and Dissemination of Technologies in Biomedical Computing, Informatics and Big Data Science - PA-14-156 (R01)
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science - PA-14-154 (R43/R44)
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science - PA-14-155 (R01)
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects - PAR-14-104 (R03)
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects - PAR-14-105 (R21)
- Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects - PAR-14-106 (R01)
- Neuroimmune Signaling and Function in Substance Use Disorders - PA-14-083 (R21)
- Neuroimmune Signaling and Function in Substance Use Disorders - PA-14-084 (R01)
- Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence - PA-14-038 (R01)
- Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence - PA-14-036 (R21)
- Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities - PA-14-025 (R01)